Financhill
Sell
28

XNCR Quote, Financials, Valuation and Earnings

Last price:
$11.59
Seasonality move :
-9.41%
Day range:
$11.36 - $11.95
52-week range:
$6.92 - $18.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.70x
P/B ratio:
1.32x
Volume:
417.3K
Avg. volume:
667.8K
1-year change:
-28.85%
Market cap:
$827.6M
Revenue:
$110.5M
EPS (TTM):
-$1.78

Analysts' Opinion

  • Consensus Rating
    Xencor, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $28.83, Xencor, Inc. has an estimated upside of 148.78% from its current price of $11.59.
  • Price Target Downside
    According to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $11.59.

Fair Value

  • According to the consensus of 10 analysts, Xencor, Inc. has 148.78% upside to fair value with a price target of $28.83 per share.

XNCR vs. S&P 500

  • Over the past 5 trading days, Xencor, Inc. has overperformed the S&P 500 by 1.28% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Xencor, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Xencor, Inc. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Xencor, Inc. reported revenues of $21M.

Earnings Growth

  • Xencor, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Xencor, Inc. reported earnings per share of -$0.08.
Enterprise value:
559M
EV / Invested capital:
--
Price / LTM sales:
5.70x
EV / EBIT:
--
EV / Revenue:
3.72x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
-4.05x
Price / Operating cash flow:
37.37x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$139.2M
Return On Assets:
-14.35%
Net Income Margin (TTM):
-87.71%
Return On Equity:
-20.07%
Return On Invested Capital:
-15.54%
Operating Margin:
-226.29%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $145.3M $85.2M $150.1M $10.7M $21M
Gross Profit $134.8M $72.8M $139.2M $7.7M $18.4M
Operating Income -$146.2M -$216.1M -$137.1M -$62.3M -$47.5M
EBITDA -$135.8M -$203.7M -$126.1M -$59.2M -$44.9M
Diluted EPS -$1.99 -$3.20 -$1.78 -$0.71 -$0.08
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $329.6M $668M $571.2M $573.3M $518.4M
Total Assets $697.3M $835.3M $778.4M $983.6M $868.8M
Current Liabilities $44.3M $90M $53M $92M $86.5M
Total Liabilities $78.4M $112.6M $109.4M $294M $243.5M
Total Equity $618.9M $722.7M $669M $720.9M $625.3M
Total Debt $34.1M $22.5M $56.4M $239.3M $198.5M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$120.5M $34.6M -$133.2M -$26M -$30.8M
Cash From Investing $116.6M -$267.8M $124.3M -$163.5M $14.7M
Cash From Financing $4.4M $209.5M $8.1M $187.7M --
Free Cash Flow -$151M $26.1M -$137.9M -$28.1M -$31M
XNCR
Sector
Market Cap
$827.6M
$24M
Price % of 52-Week High
62.01%
48.29%
Dividend Yield
0%
0%
Shareholder Yield
-3.71%
-1.62%
1-Year Price Total Return
-28.85%
-22.92%
Beta (5-Year)
0.980
0.500
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $11.71
200-day SMA
Buy
Level $11.32
Bollinger Bands (100)
Sell
Level 12.2 - 15.98
Chaikin Money Flow
Sell
Level -486.8K
20-day SMA
Sell
Level $12.26
Relative Strength Index (RSI14)
Sell
Level 38.21
ADX Line
Sell
Level 31.88
Williams %R
Neutral
Level -71.0801
50-day SMA
Sell
Level $14.26
MACD (12, 26)
Buy
Level 3.18
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Sell
Level -935K

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.5656)
Sell
CA Score (Annual)
Level (-0.3148)
Sell
Beneish M-Score (Annual)
Level (3.6205)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.5162)
Sell
Piotroski F Score (Annual)
Level (2)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Stock Forecast FAQ

In the current month, XNCR has received 9 Buy ratings 1 Hold ratings, and 0 Sell ratings. The XNCR average analyst price target in the past 3 months is $28.83.

  • Where Will Xencor, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Xencor, Inc. share price will rise to $28.83 per share over the next 12 months.

  • What Do Analysts Say About Xencor, Inc.?

    Analysts are divided on their view about Xencor, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xencor, Inc. is a Sell and believe this share price will drop from its current level to $18.00.

  • What Is Xencor, Inc.'s Price Target?

    The price target for Xencor, Inc. over the next 1-year time period is forecast to be $28.83 according to 10 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is XNCR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Xencor, Inc. is a Buy. 9 of 10 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of XNCR?

    You can purchase shares of Xencor, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xencor, Inc. shares.

  • What Is The Xencor, Inc. Share Price Today?

    Xencor, Inc. was last trading at $11.59 per share. This represents the most recent stock quote for Xencor, Inc.. Yesterday, Xencor, Inc. closed at $11.59 per share.

  • How To Buy Xencor, Inc. Stock Online?

    In order to purchase Xencor, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Is Sandisk The Next Big Memory Stock?
Is Sandisk The Next Big Memory Stock?

Computer memory manufacturer Sandisk (NASDAQ:SNDK) has quietly been one of…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock